Nalaganje...
An Updated Analysis of Four Randomized ECOG Trials of High-Dose Interferon in the Adjuvant Treatment of Melanoma
BACKGROUND: The pivotal trials of adjuvant high-dose interferon alpha (HDI) in E1684, E1690, E1694 and E2696 enrolled almost 2000 patients, and established HDI as the standard of care for adjuvant therapy of resected high-risk melanoma. Here, we present an updated analysis of these four trials. METH...
Shranjeno v:
| izdano v: | Cancer |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7428054/ https://ncbi.nlm.nih.gov/pubmed/31067358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32162 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|